Select Page ::

Biotech, Pharmaceutical, Medical Device, and Chemical …

Posted on September 8, 2016 by Fredricko

<-- Manitboa Biotech Company Name

City

Annapolis

Baltimore

Bethesda

Clarksville

Cockeysville

Columbia

Elkridge

Frederick

Fredrick

Frederick

Gaithersburg

Galena

Germantown

Glen Burnie

Hanover

Havre de Grace

Hunt Valley

Lexington Park

Rockville

Savage

Silver Spring

Sparks

Visit link:
Biotech, Pharmaceutical, Medical Device, and Chemical ...

Biotechnology, Undergraduate Programs, SUNY-ESF

Posted on July 8, 2016 by Danzig

Information for Enrolled Students Learn More

Biotechnology is the application of biological organisms, cells, or molecules to create products or services for the betterment of humans. The bachelor of science degree in biotechnology prepares students to tackle environmental, natural resource, agricultural and medical problems through training in molecular biology, cell biology, biochemistry, genetic engineering and related biological disciplines. As biotechnology is increasingly used to address such issues, it offers diverse career opportunities. The curriculum emphasizes the basic sciences with a strong foundation in biology, chemistry, calculus, and physics that prepares students for upper-level biology and chemistry courses, but encourages elective breadth in the social sciences, humanities, and environmental studies. The degree program provides sufficient breadth for a student to enter a clinical medical career, or other health profession. Students who complete this major will be qualified to enter the growing biotechnology-related job market or continue their studies in graduate or professional school.

The biotechnology major features a strong practical experience component. Each student is required to fulfill an internship, which could be in a local, national, or international company, medical unit, or government research laboratory. The objective of this internship is to give students experience working outside a purely academic setting. In addition, each student is required to perform one independent research project in a local, national, or international academic laboratory. The objective of the research requirement is to teach the student to develop and meet a research goal using the scientific method. During the senior year, each student is required to complete a senior project synthesis in which the results from either the internship or independent researchor bothwill be organized and presented as a seminar or poster.

In addition to ESF courses, below is a list of other courses offered at Syracuse University that can satisfy the directed electives requirement:

Link:
Biotechnology, Undergraduate Programs, SUNY-ESF

Biotechnology Industry News: Industry Center – Yahoo Finance

Posted on July 8, 2016 by ev1

Latest News Sunday, Jun 5, 2016 Exelixis and its partner Ipsen announce phase 3 trial results of CABOMETYX (cabozantinib) tablets demonstrating significant overall survival benefit for previously treated patients with advanced renal cell carcinoma presented at ASCO Business Wire - 10 minutes ago J&J myeloma drug, in combo regimen, delays worsening of the disease Reuters - 15 minutes ago Exelixis Announces Genentech Presentation of Preliminary Phase 1B Trial Results for the Combination of Cobimetinib and Atezolizumab at ASCO 2016 Annual Meeting Business Wire - 15 minutes ago Stemline Therapeutics SL-401 Phase 2 BPDCN Data Delivered Via Oral Presentation at ASCO; High Response Rates Demonstrated Across All Lines As Enrollment Proceeds GlobeNewswire - Sat 7:07 pm ET TESARO Provides Pipeline Update at ASCO Investor Briefing GlobeNewswire - Sat 7:00 pm ET Data Presented at ASCO 2016 Builds upon Foundation of Abraxane Plus Gemcitabine as a First-Line Treatment in Patients with Metastatic Pancreatic Cancer Business Wire - Sat 5:32 pm ET Juno Therapeutics Investigational CAR T Cell Product Candidate JCAR015 Shows High Response Rates in Adults with B-cell ALL Business Wire - Sat 5:15 pm ET Saturday, Jun 4, 2016 Celldex Therapeutics CDX1401, CDX301 Combination Generates Potent NY-ESO-1 Immune Responses in Patients with Melanoma GlobeNewswire - Sat 2:02 pm ET Juno Therapeutics Defined Composition CD19 Product Candidates Demonstrate Encouraging Clinical Outcomes and Tolerability Business Wire - Sat 10:08 am ET Five Prime Therapeutics Announces Updated Data in Mesothelioma Patients from Ongoing Phase 1b Trial of FP-1039 Presented at 2016 ASCO Annual Meeting GlobeNewswire - Sat 9:24 am ET Encorafenib-based Regimens Provide Improved PFS and OS in Difficult-to-Treat BRAF-Mutant Colorectal Cancer Compared to Historical Benchmarks PR Newswire - Sat 9:00 am ET Array BioPharma, Pierre Fabre and Merck KGaA, Darmstadt, Germany Announce Phase 3 BEACON CRC Trial PR Newswire - Sat 9:00 am ET Aduro Biotech Presents Encouraging Anti-Tumor Response Data From Ongoing Phase 1b Study in Malignant Pleural Mesothelioma at ASCO GlobeNewswire - Sat 9:00 am ET Halozyme Presents Stage One Efficacy And Safety Analysis Of Phase 2 Clinical Study In Metastatic Pancreatic Cancer Patients Treated With PEGPH20 PR Newswire - Sat 9:00 am ET ARIAD Presents Data from Mutational Profiling in Crizotinib-Resistant Patients Treated with Investigational Medicine Brigatinib Showing Similar Response Rates in Patients with and without Secondary ALK Mutations Business Wire - Sat 7:35 am ET ARIAD Presents Long-Term Phase 1/2 Trial Follow up on Investigational Drug Brigatinib with Median Time on Treatment of 17 Months in ALK+ NSCLC Patients Business Wire - Sat 7:35 am ET INTREXON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Intrexon Corporation Business Wire - Fri 10:07 pm ET June is month to watch for more IPO news at bizjournals.com - Fri 8:47 pm ET [$$] Frazier, OrbiMed Join $100M Financing for Lion Biotechnologies at The Wall Street Journal Online - Fri 8:44 pm ET Celator Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of CPXX Shareholders PR Newswire - Fri 6:21 pm ET More Latest News...

biotechnology – BIO | Healing, Fueling and Feeding the World

Posted on July 8, 2016 by ev1

Recent advances in biotechnology are helping us prepare for and meet societys most pressing challenges.

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

Modern biotechnology provides breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes.

Currently, there are more than 250 biotechnology health care products and vaccines available to patients, many for previously untreatable diseases. More than 18 million farmers around the world use agricultural biotechnology to increase yields, prevent damage from insects and pests and reduce farming's impact on the environment. And more than 50 biorefineries are being built across North America to test and refine technologies to produce biofuels and chemicals from renewable biomass, which can help reduce greenhouse gas emissions.

Recent advances in biotechnology are helping us prepare for and meet societys most pressing challenges. Here's how:

Biotech is helping toheal the worldby harnessing nature's own toolbox and using our own genetic makeup to heal and guide lines of research by:

Biotech uses biological processes such as fermentation and harnesses biocatalysts such as enzymes, yeast, and other microbes to become microscopic manufacturing plants. Biotech is helping tofuel the worldby:

Biotech improves crop insect resistance, enhances crop herbicide tolerance and facilitates the use of more environmentally sustainable farming practices. Biotech is helping tofeed the worldby:

Source: Healing, Fueling, Feeding: How Biotechnology is Enriching Your Life

See the article here:
biotechnology - BIO | Healing, Fueling and Feeding the World

Biotechnology – Ivy Tech Community College of Indiana

Posted on July 8, 2016 by ev1

The biotechnology program at Ivy Tech is taught by instructors with real-world experience. Students will use state-of-the-art laboratories that are equipped with instrumentation, supplies and equipment for an effective hands-on laboratory experience.

Classes focus on teaching a variety of procedures necessary to execute laboratory projects assigned in the students chosen field. Students will spend a significant amount of class time working hands-on doing laboratory activities either by themselves or in small groups with the ability to have one-on-one time with the instructor.

The Biotechnology Program prepares students for careers in a variety of life science and manufacturing settings including research, quality control, pharmaceuticals, and medical devise manufacturing.

Graduates will have the foundation needed to transfer to earn a bachelors degree or move right in to local, high-paying jobs in the community, including with some of our industry partners like Dow Agroscience, Eli Lilly, Cook Pharmica, Midwest Compliance Laboratories, and more. These great partnerships lead to our graduates high job placement rate.

*According to a Battelle/Biotechnology Industry Organization (BIO) Report State Biosciences Jobs, Investments and Innovation 2014.

Continued here:
Biotechnology - Ivy Tech Community College of Indiana

From the United States to Kenya, food biotechnology can deliver major benefits – Video

Posted on May 1, 2015 by ev1

From the United States to Kenya, food biotechnology can deliver major benefits
Video courtesy of FoodInsightTV https://www.youtube.com/channel/UCn2k5w1PhSWv_umuKmQkHrQ.

By: DonParavacinni

Read the original:
From the United States to Kenya, food biotechnology can deliver major benefits - Video

Top 10 biotech companies and Top 100 biotechnology places …

Posted on July 5, 2015 by Danzig

Top 10 biotech companies in India 1. Biocon Established in the year 1978 Biocon, global biopharmaceutical enterprise is actively involved in the manufacturing and development of innovative technologies that includes large-scale chemical synthesis, microbial fermentation, mammalian cell culture, purification of protein & antibody and various aseptic formulations. Chairman Kiran Mazumdar-Shaw; Corporate Office Bangalore, India | Sector Private | Website http://www.biocon.com 2. Serum Institute of India Serum Institute of India Ltd. established in the year 1966 is the world's largest producer of Measles and DTP group of vaccines. The company manufactures life-saving Biologicals including Anti-Snake Venom and Tetanus Antitoxin serum, DTP (Diphtheria, Tetanus and Pertussis) and MMR (Measles, Mumps and Rubella) group of vaccines at affordable prices. Chairman Cyrus S. Poonawalla; Location: Pune, India | Sector Private | Website http://www.seruminstitute.com 3. Panacea Biotech Ltd Panacea Biotec established in the year 1976, has strong R and D capabilities with a wide range of pipeline including: Development various complex pharmaceutical generic compounds Technologies) Development of New Chemical Entities (NCE) Vaccines Chairman Soshil Kumar, Corporate Office New Delhi, India | | Business Pharmaceutical, Biotechnology | Sector Private | Website http://www.panacea-biotec.com 4. Novo Nordisk Established in the year 1923, Novo Nordisk is the worlds leader in diabetes care, manufacturing broadest diabetes product that includes development of the most advanced products related to insulin delivery systems. Chairman Sten Scheibye, Corporate Office Denmark, Business -Sector Pharmaceutical- Private | Website http://www.novonordisk.co.in 5. GlaxoSmithKline Pharmaceuticals Ltd. One of the earliest pharmaceutical companies in India is GSK India. It was established in the year 1924. The GSK India is an important group of manufacturing products of wide range of prescription medicines and vaccines in therapeutic areas such as dermatology, anti-infectives, diabetes, oncology, cardiovascular and respiratory diseases. The company also manufactures vaccines for prevention of hepatitis A and B, invasive diseases caused by H. influenzae, chickenpox, DPT, cervical cancer, rotavirus, Streptococcal pneumonia etc. Chairman Chris Gent; Corporate Office London, United Kingdom Business Biotechnology and Pharmaceutical, Sector Private | Website http://www.gsk-india.com 6. SIRO Clinpharm Established in the year 1996 the company provides a wide range of services including Clinical Operations & Clinical Monitoring, Clinical Data management, medical and scientific writing, biostatistics and statistical programming, clinical trial supplies management, pharmacovigilance. Chairman Dr. Gautam Daftary; Corporate Office Thane, India | | | Business Drug Development; Sector Private | Website http://www.siroclinpharm.com 7. Novozymes, South Asia Novozymes a biotech company established in 1925 strongly focus on production of novel enzymes. The companys biosolution provides everything from the removal of trans fats in food to advancements in bioenergy sources. Chairman Kbenhavns Lufthavne; Corporate Office Bagsvaerd, Denmark; Novozymes South Asia Pvt. Ltd. Bangalore, India; Sector Private | Website http://www.novozymes.com 8. Zydus Cadila Zydus Cadila, established in the year 1952, is a fully integrated, global healthcare company with complete healthcare solutions ranging from active pharmaceutical ingredients, formulations products related to animal health care to wellness products. The company is the only Indian pharma establishment that launched the worlds first drug NCE Lipaglyn for treatment of diabetic dyslipidemia. Chairman - Mr. Pankaj R. Patel, Corporate office-Ahmedabad, Sector- Private Website- http://www.zyduscadila.com 9. Indian Immunologicals Indian Immunologicals Ltd. (IIL) was established in 1982 by The National Dairy Development Board (NDDB) with the focus to manufacture Foot and Mouth Disease (FMD) vaccine available to poor people at an affordable price. IIL provides a range of adult as well as child vaccines. Chairman Dr. Amrita Patel; Corporate Office Hyderabad, India Business-sector Biotechnology-private; Website http://www.indimmune.com 10. Wockhardt Ltd. Established in the year 1960 Wockhardt Ltd. is an international manufacturer of biopharmaceutical formulations along with Active Pharmaceutical Ingredients (API). An integrated multi-technology capability was developed by the company for manufacturing all types of dosage formulation that includes sterile injectables and lyophilised products. Chairman Habil Khorakiwala; Corporate Office Mumbai, India; Business Sector Biotechnology and Pharmaceutics-private Website http://www.wockhardt.com

View original post here:
Top 10 biotech companies and Top 100 biotechnology places ...

What is biotechnology? – Definition from WhatIs.com

Posted on August 26, 2015 by Danzig

Biotechnology is the use of biological processes, organisms, or systems to manufacture products intended to improve the quality of human life. The earliest biotechnologists were farmers who developed improved species of plants and animals by cross pollenization or cross breeding. In recent years, biotechnology has expanded in sophistication, scope, and applicability.

The science of biotechnology can be broken down into subdisciplines called red, white, green, and blue. Red biotechnology involves medical processes such as getting organisms to produce new drugs, or using stem cells to regenerate damaged human tissues and perhaps re-grow entire organs. White (also called gray) biotechnology involves industrial processes such as the production of new chemicals or the development of new fuels for vehicles. Green biotechnology applies to agriculture and involves such processes as the development of pest-resistant grains or the accelerated evolution of disease-resistant animals. Blue biotechnology, rarely mentioned, encompasses processes in marine and aquatic environments, such as controlling the proliferation of noxious water-borne organisms.

Biotechnology, like other advanced technologies, has the potential for misuse. Concern about this has led to efforts by some groups to enact legislation restricting or banning certain processes or programs, such as human cloning and embryonic stem-cell research. There is also concern that if biotechnological processes are used by groups with nefarious intent, the end result could be biological warfare.

Also see nanotechnology and genetic engineering .

This was last updated in May 2007

Go here to read the rest:
What is biotechnology? - Definition from WhatIs.com

Endoret (PRGF) BTI Biotechnology Institute – Video

Posted on April 26, 2015 by ev1

Endoret (PRGF) BTI Biotechnology Institute
Endoret (PRGF) BTI Biotechnology Institute United Kingdom.

By: Castle Hill Clinic

Original post:
Endoret (PRGF) BTI Biotechnology Institute - Video

Biotechnology getting raked $IBB $AMGN $ALXN $BIIB $CELG $ILMN – Video

Posted on April 29, 2015 by Danzig

Biotechnology getting raked $IBB $AMGN $ALXN $BIIB $CELG $ILMN
When a hot sector turns, you don #39;t want to be in it. Biotechnology has been the hottest of hot as this market has climbed higher moving some 300% higher over the past three years. Phenomenal...

By: LA Little

View original post here:
Biotechnology getting raked $IBB $AMGN $ALXN $BIIB $CELG $ILMN - Video

AP Industry Mission @ automobile,Agriculture, agri-biotech,biotechnology,IT,Pharmaceuticals,pharma – Video

Posted on May 1, 2015 by Danzig

AP Industry Mission @ automobile,Agriculture, agri-biotech,biotechnology,IT,Pharmaceuticals,pharma
please note:poor quality video Release by I PR Department of AP ................................................................................................ The launch of Industry Mission...

By: VIZAG NEWS

See the original post:
AP Industry Mission @ automobile,Agriculture, agri-biotech,biotechnology,IT,Pharmaceuticals,pharma - Video

Biotechnology (B.S.) at FGCU – Video

Posted on April 22, 2015 by ev1

Biotechnology (B.S.) at FGCU
Students in the B.S. in Biotechnology program will gain an understanding of living organisms at the cellular and molecular level. The curriculum emphasizes hands-on learning and provides undergrad.

By: fgcu

Read this article:
Biotechnology (B.S.) at FGCU - Video

The Samba Of Shamba PT 2: Biotechnology – Video

Posted on April 25, 2015 by ev1

The Samba Of Shamba PT 2: Biotechnology

By: Kenya CitizenTV

Original post:
The Samba Of Shamba PT 2: Biotechnology - Video

BLACK OPS 3 OFFICIAL TRAILER BREAKDOWN BIOTECHNOLOGY CONFIRMED COD BO3 – Video

Posted on April 26, 2015 by ev1

BLACK OPS 3 OFFICIAL TRAILER BREAKDOWN BIOTECHNOLOGY CONFIRMED COD BO3
black ops 3,black ops 3 teaser,black ops 3 trailer,black ops 3 gameplay,call of duty black ops 3,call of duty black ops 3 teaser,call of duty black ops 3 trailer,call of duty black ops 3 gameplay,c...

By: MrLolAleshka Let #39;s Play

Continued here:
BLACK OPS 3 OFFICIAL TRAILER BREAKDOWN BIOTECHNOLOGY CONFIRMED COD BO3 - Video

Biotechnology at Tweed – Video

Posted on April 18, 2015 by ev1

Biotechnology at Tweed
animation created by: agence zigzag based on an original idea

By: Jean-Paul Lorand, Scientific Director of Tweed laboratory editorial committee and scenario: Groupe Nutriset / Odet / agence...

By: Agence zigzag

Go here to see the original:
Biotechnology at Tweed - Video

Biotechnology Department – Video

Posted on April 19, 2015 by Danzig

Biotechnology Department
Professor Dhanapalan College Of Arts And Science - Department of Biotechnology.

By: Dhanapalan College

Biotechnology | Wolf Greenfield

Posted on July 8, 2016 by ev1

G R O U P S T A T S

When it comes to advanced scientific degrees, we field the largest biotechnology group in New England 36 members, over 80% of whom have PhDs or MDs. We aggressively recruit people who develop advanced technology, and who speak the language of inventors and scientists, quickly grasping complex biotechnology matters.

Our clients include both large and emerging biotech companies such as Biogen, Dyax Corporation, and Lantheus Medical Imaging, privately financed startup companies,and prestigious academic and research institutions, including MIT, Dana Farber Cancer Institute, and Harvard Medical School. We understand the different needs of each client and bring practical solutions to the table.

Our expertise is broadand deep, covering areas from antibodies to transgenic technologiesand everything inbetween. We also call on members of our other practice groups includingChemical & Materials Technologies and Pharmaceuticalwhen their specialized expertise will benefit a clients project. In addition, our teams routinely include support from our paralegal group and our International Filing Department to contain costs and deliver value.

Our group's services include: IP strategic planning; patent portfolio development, acquisition, and enforcement; studies on patentability, infringement, and validity; IP audits and due diligence; licensing and technology transfer; defending and challenging patent validity, including post-grant proceedings; and freedom to operate and competitor analyses.

Representative clients:

For older news items, please go to News & Events.

Laura Vogel presents at ACI Conference

Wolf Greenfield and Client Cold Spring Harbor Laboratory Prevail in 4 IPRs

A.J. Tibbetts and Ed Walsh Present at BBA's 16th Annual Intellectual Property Year in Review

Wolf Greenfield Welcomes Counsel Laura Vogel

Wolf Greenfield and Client BTG Reach Favorable Outcome in IPR for CroFab Rattlesnake Antivenom Patent

LMG Life Sciences Recognizes Wolf Greenfield

Wolf Greenfield Welcomes Shareholder Jeffrey Hsi, Expert in Technology Commercialization

Wolf Greenfield Recognized in 2016 "Best Law Firms" Rankings

23 Wolf Greenfield Attorneys Named to 2015 Massachusetts Super Lawyers List

24 Wolf Greenfield Lawyers Named to 2015 Massachusetts Rising Stars List

Oona Johnstone interviewed by ASHG for Featured Chat Fridays

Managing IP Magazine Recognizes Wolf Greenfield

Favorable Outcome for BTG in Snake Antivenom ITC Investigation

Chelsea Loughran talks about CRISPR in Xconomy

20 Wolf Greenfield Lawyers Named to 2014 Massachusetts Rising Stars List

22 Wolf Greenfield Attorneys Named to 2014 Massachusetts Super Lawyers List

Pat Granahan comments on the battle to own CRISPR

Pat Granahan and Chelsea Loughran quoted on CRISPR-Cas in Nature Biotechnology

Patrick Waller interviewed by Radio Entrepreneurs

GenomeWeb quotes Chelsea Loughran on IP landscape surrounding CRISPR-Cas9

Wolf Greenfield Recognized by Managing IP Magazine

Chelsea Loughran quoted in The Scientist on first awarded CRISPR-Cas9 patent

Chelsea Loughran quoted in MIT Tech Review on first awarded patent for engineered CRISPR-Cas9 system

Doug Wolf featured as the Entrepreneur.com expert for the month of March

G R O U P S T A T S

Representative clients:

For older news items, please go to News & Events.

Laura Vogel presents at ACI Conference

Wolf Greenfield and Client Cold Spring Harbor Laboratory Prevail in 4 IPRs

A.J. Tibbetts and Ed Walsh Present at BBA's 16th Annual Intellectual Property Year in Review

Wolf Greenfield Welcomes Counsel Laura Vogel

Wolf Greenfield and Client BTG Reach Favorable Outcome in IPR for CroFab Rattlesnake Antivenom Patent

LMG Life Sciences Recognizes Wolf Greenfield

Wolf Greenfield Welcomes Shareholder Jeffrey Hsi, Expert in Technology Commercialization

Wolf Greenfield Recognized in 2016 "Best Law Firms" Rankings

23 Wolf Greenfield Attorneys Named to 2015 Massachusetts Super Lawyers List

24 Wolf Greenfield Lawyers Named to 2015 Massachusetts Rising Stars List

Oona Johnstone interviewed by ASHG for Featured Chat Fridays

Managing IP Magazine Recognizes Wolf Greenfield

Favorable Outcome for BTG in Snake Antivenom ITC Investigation

Chelsea Loughran talks about CRISPR in Xconomy

20 Wolf Greenfield Lawyers Named to 2014 Massachusetts Rising Stars List

22 Wolf Greenfield Attorneys Named to 2014 Massachusetts Super Lawyers List

Pat Granahan comments on the battle to own CRISPR

Pat Granahan and Chelsea Loughran quoted on CRISPR-Cas in Nature Biotechnology

Patrick Waller interviewed by Radio Entrepreneurs

GenomeWeb quotes Chelsea Loughran on IP landscape surrounding CRISPR-Cas9

Wolf Greenfield Recognized by Managing IP Magazine

Chelsea Loughran quoted in The Scientist on first awarded CRISPR-Cas9 patent

Chelsea Loughran quoted in MIT Tech Review on first awarded patent for engineered CRISPR-Cas9 system

Doug Wolf featured as the Entrepreneur.com expert for the month of March

Some areas of expertise

Read more from the original source:
Biotechnology | Wolf Greenfield

Biology: MS in Biotechnology – California State University …

Posted on July 8, 2016 by ev1

The Master's in Biotechnology Program is a Professional Science Master's Program, approved by the Council of Graduate Schools. This application focused graduate program is designed to train students in biotechnology. We are preparing the next generation of leaders in biotechnology.

This Section Contains

Our graduates are:

TOP

Biotechnology is a multidisciplinary endeavor that increasingly requires employees fluent in both science and business to enable the development of new technologies and products based on the unique applications of the cellular and molecular life sciences. The Master's Degree in Biotechnology at the California State University, Fresno offers students, who are fundamentally educated in various scientific disciplines, the opportunities to acquire the knowledge and skills required to comprehend and commercialize these emerging technologies and/or their products.

TOP

As a leading university in the Central Valley, California State University, Fresno will lead the way for new and innovative applications of biotechnology both in the state and throughout the nation.

TOP

NC Biotech CEO Doug Edgeton: ‘We will lead science behind curative gene, cell therapies" – WRAL Tech Wire

Posted on February 2, 2020 by Danzig

Editors note:Doug Edgeton, President and CEO of the North Carolina Biotechnology Center.

RESEARCH TRIANGLE PARK For the better part of four decades, North Carolina has steadily committed resources to developing biotechnologies and a life science cluster via the North Carolina Biotechnology Center. Through the work of many researchers, entrepreneurs, service providers, state and federal policy makers, and partners, North Carolina has grown its life science cluster from a handful of companies to 735 today.

As we begin to bridge our fifth decade of work, this National Biotechnology Month is an opportunity to show pride in the 66,000 people who make their living in this clean industry.

From the minds of North Carolina researchers, important advances still improve our quality of life today. North Carolinas prize-winning science brought us a model to study a broad spectrum of disease, a method for improving crop yield, and a contrarian yet correct approach to treating Alzheimers.

Today, North Carolina companies produce a range of medicines, diagnostic tests, improved crops and bio-based fuel that influence our lives every day. And in the coming decade North Carolina will lead the way with both the science behind and production of potentially curative gene and cell therapies.

Speakers at the 35th anniversary of the NC Biotech Center included, left to right: Aaron Lazarus, Doug Edgeton, John Rabby, Karen LeVert, Mary Beth Thomas, Bill Bullock. Photo by SP Murray for NC Biotech.

North Carolina has done this with a focus on raising up its population with world-class training programs, emulated across the U.S. and even internationally. With a combination of community college and university training, North Carolinians in both urban and rural areas are able to secure these high-paying jobs manufacturing important products in a clean environment. Nowhere is this better seen than in the BioPharma Crescent, a five-county area of rural eastern North Carolina. Through deliberate attention to infrastructure and training, this region has built a cluster of companies that employs 10,000 from a wide swath of rural North Carolina.

Biotechnology has made a similar positive impact on our states historic strength of agriculture. Cotton, soybeans and corn dominate the Coastal Plain, while underground North Carolina produces the worlds largest supply of sweet potatoes. A vast diversity of plants in western North Carolina provides the source for nutritional supplements. Our specialty crop farmers benefit from targeted research, and a consortium of researchers are uncovering new sources of animal feed with enhanced nutrition, grown right here in North Carolina.

In Kannapolis, researchers from a broad coalition of universities are matching nutrition, physical performance and longevity to extend the quality and length of lives.

The list of opportunities those realized and those yet to be goes on. From a trailer on the University of North Carolina at Chapel Hill campus came the global contract research and testing industry. In Winston-Salem, a biotech campus rose from a cluster of tobacco facilities. And for retiring veterans and high school seniors alike, targeted programs are opening up new opportunities for pharmaceutical manufacturing jobs.

Biotechnology and the life sciences have a long and broad history in North Carolina. On behalf of the North Carolina life science community, the North Carolina Biotechnology Center looks forward to the coming decade, to catalyzing the solutions that will make life better for North Carolinians, Americans, and people around the globe. With so much success behind us, there can only be greater promise ahead.

Here is the original post:
NC Biotech CEO Doug Edgeton: 'We will lead science behind curative gene, cell therapies" - WRAL Tech Wire

Biotechnology – The New York Times

Posted on July 8, 2016 by Danzig